LONDON, June 5 (Reuters) - Doctors in Europe can continue to use Sanofi-Aventis SA's heparin medicine Lovenox, despite low levels of contamination found in some batches of the product, the European ...

Rockville, MD - The FDA's MedWatch program and Aventis Pharmaceuticals have issued a reminder to physicians about the use of enoxaparin (Lovenox TM) in patients with renal impairment. According to ...

(Reuters) - The U.S. Food and Drug Administration issued a new warning on the use of the anticoagulant Lovenox in patients fitted with a spinal catheter because of the risk of spinal column bleeding ...

Aug. 18, 2004 — The U.S. Food and Drug Administration (FDA) and Aventis Pharmaceuticals notified healthcare professionals in March of revisions to the precautions section of drug labeling for ...

BRIDGEWATER, N.J., Feb. 7 (UPI) -- Sanofi-aventis said Wednesday the U.S. Food and Drug Administration granted its blood-thinner Lovenox priority review for acute heart attack. The company said it is ...

Uninsured people who paid out of pocket for the anticoagulant drug Lovenox may be eligible for a payment from a $120 million proposed settlement in a dispute between Nashville General Hospital and two ...

Well, we sort of figured this was coming. Sanofi-Aventis has gone to court here in Washington to prevent rival drugmaker Novartis from selling a generic version of the blockbuster blood-thinner ...

Yesterday a judge put off a ruling on Sanofi-Aventis's request to keep a generic version of its anti-clotting drug Lovenoxfrom hitting the market, saying he needed more time to review the details of ...